These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Obes Surg; 2006 Dec 10; 16(12):1584-93. PubMed ID: 17217634 [Abstract] [Full Text] [Related]
10. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Miele L, Forgione A, Gasbarrini G, Grieco A. Transl Res; 2007 Mar 10; 149(3):114-25. PubMed ID: 17320797 [Abstract] [Full Text] [Related]
11. Pathology of nonalcoholic fatty liver disease. Yeh MM, Brunt EM. Am J Clin Pathol; 2007 Nov 10; 128(5):837-47. PubMed ID: 17951208 [Abstract] [Full Text] [Related]
12. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S, Yukawa T, Uetake S, Yamauchi M. Alcohol Clin Exp Res; 2007 Jan 10; 31(1 Suppl):S83-7. PubMed ID: 17331172 [Abstract] [Full Text] [Related]
13. [NASH -- nonalcoholic steatohepatitis]. Blechacz B, Stremmel W. Z Gastroenterol; 2003 Jan 10; 41(1):77-90. PubMed ID: 12541180 [Abstract] [Full Text] [Related]
14. [Nonalcoholic steatohepatitis: pathogenesis and treatment]. Park SH. Korean J Hepatol; 2008 Mar 10; 14(1):12-27. PubMed ID: 18367854 [Abstract] [Full Text] [Related]